Dyslipidemia Management in 2026: New Guidelines, Tailored Strategies, Real-World Application for Your Nutrition Practice

Your Price

Dyslipidemia management is evolving rapidly - and so is the RDN's role in it. This session brings together a leading endocrinologist/lipidologist and two dietitians specializing in cardiovascular nutrition to deliver a clinically rigorous, practice-ready update on dyslipidemia management.

Attendees will gain a better understanding of what's new in research on lipoprotein lipids in cardiovascular risk and in the 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia. We'll cover new approaches for risk classification; the distinction between 10-year and lifetime cardiovascular risk; and the expanding role of apolipoprotein B, lipoprotein(a), and coronary artery calcium scoring in clinical decision-making. The Guideline's treatment algorithm will be placed in the context of shared decision-making with patients.

Two RDN experts will then translate this framework into nutrition practice. Topics include tailored strategies for management of different types of dyslipidemia, a stepwise approach from baseline to more intensive intervention, and how medical nutrition therapy fi ts alongside - and extends beyond - the 2025 Dietary Guidelines for Americans. Presenters will also address persistent nutrition misinformation circulating on social media and share practical strategies and tools to help people overcome barriers to implementing nutrition therapy for dyslipidemia.

The session closes with a moderator-led interactive discussion and audience Q&A.

Planned with the Committee for Lifelong Learning

Product Publish Details

CPEU: 1.50 (Valid Until September 15, 2029)

Learning Objectives

Summarize current research and what's new in evidence-based recommendations on dyslipidemia and its diagnosis, relationship to atherosclerotic cardiovascular disease risk and other risks (e.g., pancreatitis with severe hypertriglyceridemia), and treatment.
Choose evidence-supported nutrition interventions based on mechanisms causing different types of dyslipidemia, and adapt them based on individual response.
Translate current nutrition recommendations for dyslipidemia management into practical individualized strategies that promote cardiovascular health and reduce risk of other conditions related to dyslipidemia.

Performance Indicators

9.2.4 Integrates new knowledge of disease states and clinical conditions into practice.
10.6.3 Applies counseling principles and evidence-based practice when providing individual or group education.
11.3.4 Selects interventions intended to resolve or improve nutrition diagnoses through addressing the causes and/or contributing factors.

Check Out Our Current Sales

From seasonal specials celebrating commemorative events and awareness campaigns to sales on soon-to-expire CPE activities and book titles for which new editions are just around the corner, don't miss this opportunity to grab cutting-edge resources at discounted prices.